Evaluation of preemptive effects of intravenous acetaminophe in viteroretinal surgery
Not Applicable
- Conditions
- Vitreoretinal surgery.Other retinal disorders
- Registration Number
- IRCT201311139213N3
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 83
Inclusion Criteria
inclusion criteria: Age between 18 to 70 years
exclusion criteria: opioid use within past 48 hours; psychological and neurologic disease; sever heart disease; sever liver disease; sever kidney disease; hematologic disease; metabolic and physical disease; history of chronic pain;
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: recovery, 2h after surgery.4h after surgery.24h after surgery. Method of measurement: Pain from 1 to 10 based on VRS score will be recorded.
- Secondary Outcome Measures
Name Time Method ausa. Timepoint: ricovery, 2h after surgery,4 hour after surgery, 24h surgery. Method of measurement: Its presence or absence is recorded.;Vomit. Timepoint: ricovery, 2h after surgery,4 hour after surgery, 24h surgery. Method of measurement: Its presence or absence is recorded.;Shivering. Timepoint: recovery. Method of measurement: Its presence or absence is recorded.